Log In
BCIQ
Print this Print this
 

Calcium channel modulator

  Manage Alerts
Collapse Summary General Information
Company Lectus Therapeutics Ltd.
DescriptionN-type (Cav2.2) calcium channel modulator
Molecular Target
Mechanism of ActionN-type (Cav2.2) calcium channel modulator
Therapeutic Modality 
Latest Stage of DevelopmentDiscovery
Standard IndicationPain
Indication DetailsTreat neuropathic pain
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today